Announced Tue, 27 Oct, 2026 · 18:04 IST
Corporate governance report not required for September 2026 quarter
MONOPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Mono Pharmacare said the corporate governance report for the quarter ended September 30, 2026 was not required because its equity shares are listed on the SME exchange. It cited the applicable SEBI exemption and asked NSE to update its records.
Likely market impact
Routine regulatory clarification with no direct change to operations, earnings, or shareholder value.